Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer

Authors

Neel Shah, Memorial Sloan Kettering Cancer Center
Ping Wang, Albert Einstein College of Medicine
John Wongvipat, Memorial Sloan Kettering Cancer Center
Wouter R. Karthaus, Memorial Sloan Kettering Cancer Center
Wassim Abida, Memorial Sloan Kettering Cancer Center
Joshua Armenia, Memorial Sloan Kettering Cancer Center
Shira Rockowitz, Albert Einstein College of Medicine
Yotam Drier, Massachusetts General Hospital and Harvard Medical School
Bradley E. Bernstein, Massachusetts General Hospital and Harvard Medical School
Henry W. Long, Dana-Farber Cancer Institute and Harvard Medical School
Matthew L. Freedman, Dana-Farber Cancer Institute and Harvard Medical School
Vivek K. Arora, Washington University School of Medicine in St. Louis
Deyou Zheng, Albert Einstein College of Medicine
Charles L. Sawyers, Memorial Sloan Kettering Cancer Center

Journal

Elife

Publication Date

2017

Volume

6

Inclusive Pages

e27861

Document Type

Open Access Publication

DOI

10.7554/eLife.27861

Rights and Permissions

Neel Shah, et al. 2017. Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer. Elife. 2017 Sep 11;6. pii: e27861. doi: 10.7554/eLife.27861.

Recommended Citation

Shah, Neel; Wang, Ping; Wongvipat, John; Karthaus, Wouter R.; Abida, Wassim; Armenia, Joshua; Rockowitz, Shira; Drier, Yotam; Bernstein, Bradley E.; Long, Henry W.; Freedman, Matthew L.; Arora, Vivek K.; Zheng, Deyou; and Sawyers, Charles L., "Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer." Elife. 6, e27861. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6158